These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 21649564

  • 1. Cyclosporine versus tacrolimus maintenance therapy in renal transplant.
    Alghamdi S, Nabi Z, Skolnik E, Alkorbi L, Albaqumi M.
    Exp Clin Transplant; 2011 Jun; 9(3):170-4. PubMed ID: 21649564
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 3. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
    Boots JM, van Duijnhoven EM, Christiaans MH, Nieman FH, van Suylen RJ, van Hooff JP.
    Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
    [Abstract] [Full Text] [Related]

  • 4. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC, Hwang EA, Han SY, Park SB, Kim HT, Cho WH.
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [Abstract] [Full Text] [Related]

  • 5. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
    Kobashigawa JA, Patel J, Furukawa H, Moriguchi JD, Yeatman L, Takemoto S, Marquez A, Shaw J, Oeser BT, Subherwal S, Wu GW, Kawano J, Laks H.
    J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
    Krämer BK, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Ortuño J, Sester U, Kunzendorf U, Dietl KH, Bonomini V, Rigotti P, Ronco C, Tabernero JM, Rivero M, Banas B, Mühlbacher F, Arias M, Montagnino G, European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2008 Jul; 23(7):2386-92. PubMed ID: 18258740
    [Abstract] [Full Text] [Related]

  • 7. Long-term graft function with tacrolimus and cyclosporine in renal transplantation: paired kidney analysis.
    Cheung CY, Chan HW, Liu YL, Chau KF, Li CS.
    Nephrology (Carlton); 2009 Dec; 14(8):758-63. PubMed ID: 20025685
    [Abstract] [Full Text] [Related]

  • 8. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B.
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [Abstract] [Full Text] [Related]

  • 9. Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine.
    Castel MA, Farrero M, Vallejos I, Cardona M, Regueiro A, Pérez-Villa F.
    Transplant Proc; 2011 Jan; 43(6):2244-6. PubMed ID: 21839245
    [Abstract] [Full Text] [Related]

  • 10. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM, Andrés A, Dominguez-Gil B, Arriola M, Gutiérrez MJ, Hernández E, Ortuño T, Praga M.
    Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
    [Abstract] [Full Text] [Related]

  • 11. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 12. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
    Jevnikar A, Arlen D, Barrett B, Boucher A, Cardella C, Cockfield SM, Rush D, Paraskevas S, Shapiro J, Shoker A, Yilmaz S, Zaltzman JS, Kiberd B.
    Transplantation; 2008 Oct 15; 86(7):953-60. PubMed ID: 18852662
    [Abstract] [Full Text] [Related]

  • 13. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 14. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY, Wong KM, Chan HW, Liu YL, Chan YH, Wong HS, Chak WL, Choi KS, Chau KF, Li CS.
    Transpl Int; 2006 Aug 15; 19(8):657-66. PubMed ID: 16827683
    [Abstract] [Full Text] [Related]

  • 15. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 15; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 16. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
    Bolin P, Shihab FS, Mulloy L, Henning AK, Gao J, Bartucci M, Holman J, First MR, OPTIMA Study Group.
    Transplantation; 2008 Jul 15; 86(1):88-95. PubMed ID: 18622283
    [Abstract] [Full Text] [Related]

  • 17. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
    Cheung CY, Liu YL, Wong KM, Chan HW, Chan YH, Wong HS, Chak WL, Choi KS, Chau KF, Shek CC, Li CS.
    Nephrology (Carlton); 2008 Jun 15; 13(3):251-5. PubMed ID: 18221256
    [Abstract] [Full Text] [Related]

  • 18. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan 15; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 19. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
    Chamienia A, Biedunkiewicz B, Król E, Debska-Slizień A, Rutkowski B.
    Transplant Proc; 2006 Jan 15; 38(1):81-5. PubMed ID: 16504670
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T, CRAF Study Group.
    Clin Transplant; 2005 Oct 15; 19(5):573-80. PubMed ID: 16146546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.